Cargando…

Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature

BACKGROUND: Primary central nervous system lymphoma(PCNSL) is a rare kind of non-Hodgkin lymphoma. Rituximab combined with high-dose methotrexate, cytarabine and dexamethasone (R-MAD regimen) were reported effective for PCNSL patients. Rituximab can cause several side effects, including fever, chill...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yuchen, Sun, Xuefei, Liu, Jing, Qian, Jun, Bai, Xueyan, Chen, Yuedan, Liu, Yuanbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393842/ https://www.ncbi.nlm.nih.gov/pubmed/32922862 http://dx.doi.org/10.1186/s41016-017-0106-3

Ejemplares similares

Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma
por: Sun, Xuefei, et al.
Publicado: (2017)

Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
por: Bai, Xueyan, et al.
Publicado: (2015)

Efficacy and Safety of Ibrutinib in Central Nervous System Lymphoma: A PRISMA-Compliant Single-Arm Meta-Analysis
por: Lv, Liwei, et al.
Publicado: (2021)

Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study
por: Wu, Yuchen, et al.
Publicado: (2021)

Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population
por: Wu, Yuchen, et al.
Publicado: (2019)

Expression of hypoxia‐inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors
por: Shen, Na, et al.
Publicado: (2020)

Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy
por: Lee, Yuna, et al.
Publicado: (2006)

The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis
por: Zhang, Xiaowei, et al.
Publicado: (2022)

Rituximab-CHOP Induced Interstitial Pneumonitis in Patients with Disseminated Extranodal Marginal Zone B Cell Lymphoma
por: Kim, Kwang Min, et al.
Publicado: (2008)

The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020)

Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China
por: Sun, Xuefei, et al.
Publicado: (2022)

Interstitial pneumonitis following intrapleural chemotherapy
por: Zappa, Luis, et al.
Publicado: (2009)

The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
por: Van Dijck, Ruben, et al.
Publicado: (2021)

Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis
por: Ichikawa, Satoshi, et al.
Publicado: (2013)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2022)

Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab-Containing Chemotherapy
por: Fernandez-Alvarez, Ruben, et al.
Publicado: (2014)

Treatment outcome in children with central nervous system-positive Burkitt lymphoma using only intrathecal and systemic chemotherapy combined with rituximab
por: Huang, Shuang, et al.
Publicado: (2021)

Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
por: Murakami, Mineko, et al.
Publicado: (2011)

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab
por: Kuwahara-Ota, Saeko, et al.
Publicado: (2018)

Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma
por: Zhao, Defeng, et al.
Publicado: (2014)

Fatal Interstitial Pneumonitis Rapidly Developed after the First Cycle of CHOP with Etoposide Combination Chemotherapy in a Patient with Lymphoma
por: Park, Hyung Chul, et al.
Publicado: (2013)

Neoadjuvant Chemotherapy with Laser Interstitial Thermal Therapy in Central Nervous System Neuroblastoma: Illustrative Case and Literature Review
por: Chung, Jason E., et al.
Publicado: (2023)

Docetaxel-related interstitial pneumonitis
por: Wang, Chung-Jen, et al.
Publicado: (2015)

Bucillamine‐induced interstitial pneumonitis
por: Nakamoto, Keitaro, et al.
Publicado: (2018)

Trastuzumab-Induced Interstitial Pneumonitis
por: Errisuriz, Kimberly, et al.
Publicado: (2023)

Rituximab-induced pneumonitis mimicking miliary tuberculosis
por: Yao, Chih-Wei, et al.
Publicado: (2013)

Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience
por: Suleman, Adam, et al.
Publicado: (2022)

A Case of Pulmonary MALT Lymphoma Arising from Lymphocytic Interstitial Pneumonitis
por: Park, Ki Hoon, et al.
Publicado: (2012)

P1565: INCIDENCE OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH B-LINEAGE LYMPHOMA RECEIVING CHEMOTHERAPY CONTAINING RITUXIMAB
por: Liang, Xiping Xiping, et al.
Publicado: (2023)

Pemetrexed-Induced Interstitial Pneumonitis: A Case Study and Literature Review
por: Waters, Michael J., et al.
Publicado: (2014)

Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review
por: Costa, Ricardo, et al.
Publicado: (2017)

Chlorambucil-Induced Acute Interstitial Pneumonitis
por: Shafqat, Hammad, et al.
Publicado: (2014)

Sirolimus induced granulomatous interstitial pneumonitis
por: Ussavarungsi, Kamonpun, et al.
Publicado: (2012)

Nivolumab: Interstitial pneumonitis: case report
Publicado: (2020)

Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern
por: Cao, Meng-Shu, et al.
Publicado: (2019)

Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma
por: Yuan, Xianggui, et al.
Publicado: (2022)

Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival
por: Keefer, Kimberly, et al.
Publicado: (2018)

The role of local radiotherapy following rituximab‐containing chemotherapy in patients with transformed indolent B‐cell lymphoma
por: Nozaki, Kenji, et al.
Publicado: (2020)

Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders
por: Patil, Varsha A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fubrgvifqifbj2iogetrg062bq